EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

SGS INCREASES BIOSAFETY TESTING CAPACITY AT ITS GLASGOW FACILITY

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...
28 October 2021 Asia Pacific | Australasia | Europe | news | North America | Regional News biosafety | BSL-2 laboratories
Continue Reading →
Europe

SGS’s Outstanding Work Recognized by Customers at the CRO Leadership Awards 2021

For the fifth consecutive year, SGS Health Science has been recognized by the exclusive CRO Leadership Awards. In the 2021 awards, SGS was delighted to win three awa...
27 April 2021 Europe | news
Continue Reading →
Europe

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term Ahead of CPhI Discover (17th-28th May 2021) – global pharma’s larg...
26 April 2021 Europe | news
Continue Reading →
Europe

SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical, Inc. (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-...
30 March 2021 Europe | news
Continue Reading →
Europe

SGS Nominated for Best Contract Research Organization at the ViE Awards

We are excited to announce that we have been nominated for ‘Best Contract Research Organization’ at the Vaccine industry Excellence (ViE) Awards, after winning the ‘...
25 March 2021 Europe
Continue Reading →
Europe

Tezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients

Tezepelumab demonstrated superiority versus placebo across every primary and keysecondary endpoint in NAVIGATOR Phase III trial Positive full results from the pivo...
1 March 2021 Europe | North America
Continue Reading →
Europe

Vectura, Kinaset Therapeutics set to develop inhaled asthma drug

UK-based Vectura Group has signed an agreement with Kinaset Therapeutics to develop and commercialise a preclinical inhaled pan-JAK inhibitor for the treatment of se...
3 December 2020 Europe | Regional News
Continue Reading →
Europe

Boehringer Ingelheim features Queen Latifah, Bernie Williams in new lung disease documentary

Actor and musician Queen Latifah and retired All-Star baseball player Bernie Williams have both lost parents to interstitial lung disease and both already serve as B...
3 December 2020 Europe | Regional News | Uncategorised
Continue Reading →
Europe

Indivior faces lawsuit from ex-parent company RB over Suboxone marketing scheme

Indivior has taken hit after hit from U.S. prosecutors for its marketing of Suboxone Film, a notorious addiction therapy treatment. With one executive in jail and bi...
3 December 2020 Europe | Regional News
Continue Reading →
Europe

Roche, Blueprint catch up with Lilly as Gavreto snags FDA thyroid cancer nod

When Roche and Blueprint Medicine’s Gavreto got the FDA go-ahead in September to challenge Eli Lilly’s first-to-market Retevmo, the newer entrant lacked an indicatio...
3 December 2020 Europe | Regional News | Uncategorised
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte